| 000 | 02403 a2200613 4500 | ||
|---|---|---|---|
| 005 | 20250516114104.0 | ||
| 264 | 0 | _c20130924 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2012.09.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKlotz, Laurence H | |
| 245 | 0 | 0 |
_aA phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) study. _h[electronic resource] |
| 260 |
_bEuropean urology _cMay 2013 |
||
| 300 |
_a927-35 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAbsorptiometry, Photon |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlendronate _xadministration & dosage |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCanada |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aCollagen Type I _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aHip Joint _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aLeuprolide _xadministration & dosage |
| 650 | 0 | 4 |
_aLumbar Vertebrae _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xblood |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPeptides _xblood |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMcNeill, Irene Y | |
| 700 | 1 | _aKebabdjian, Marlene | |
| 700 | 1 | _aZhang, Liying | |
| 700 | 1 | _aChin, Joseph L | |
| 773 | 0 |
_tEuropean urology _gvol. 63 _gno. 5 _gp. 927-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2012.09.007 _zAvailable from publisher's website |
| 999 |
_c22161910 _d22161910 |
||